News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Plenge Robert M
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/07/2023 |
4
| Plenge Robert M (EVP, Chief Research Officer) has filed a Form 4 on BRISTOL MYERS SQUIBB CO|
Txns:
| Sold 732 shares
@ $61.14, valued at
$44.8k
|
|
| 08/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/05/2023 |
3
| Plenge Robert M (EVP, Chief Research Officer) has filed a Form 3 on BRISTOL MYERS SQUIBB CO |
| 09/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2020 |
4
| Plenge Robert M (Director) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Granted 18,900 options to buy
@ $15.33, valued at
$289.7k
|
|
| 06/19/2019 |
4
| Plenge Robert M (Director) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Granted 18,900 options to buy
@ $10.2, valued at
$192.8k
|
|
| 04/11/2019 |
4
| Plenge Robert M (Director) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Granted 37,800 options to buy
@ $12.36, valued at
$467.2k
|
|
| 04/11/2019 |
3
| Plenge Robert M (Director) has filed a Form 3 on Translate Bio, Inc. |
|
|